AG˹ٷ

STOCK TITAN

[NT 10-Q] ModivCare Inc. SEC Filing

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
NT 10-Q
Rhea-AI Filing Summary

ModivCare Inc. notified the SEC that it cannot timely file its Quarterly Report for the quarter ended June 30, 2025 because it needs more time to complete a goodwill impairment assessment and to finish an outside-counsel investigation, directed by the Audit Committee, into compliance hotline allegations including matters related to the company’s culture. The company says these matters are material to its consolidated interim financial statements.

ModivCare also warns that consolidated revenue, EBITDA and Adjusted EBITDA for the quarter are expected to be significantly lower versus the prior-year period, driven in part by an expected goodwill impairment of not less than $250 million, which could be larger as the assessment continues.

ModivCare Inc. ha informato la SEC di non poter depositare tempestivamente il proprio rapporto trimestrale relativo al trimestre chiuso il 30 giugno 2025, perché necessita di tempo aggiuntivo per completare una valutazione di svalutazione dell'avviamento (goodwill) e per concludere un'indagine svolta da consulenti esterni, disposta dal Comitato di Revisione, sulle segnalazioni per la compliance hotline, incluse questioni legate alla cultura aziendale. L'azienda dichiara che tali questioni sono rilevanti per i suoi bilanci consolidati interinali.

ModivCare avverte inoltre che i ricavi consolidati, l'EBITDA e l'Adjusted EBITDA del trimestre dovrebbero essere significativamente inferiori rispetto allo stesso periodo dell'anno precedente, in parte per via di una prevista svalutazione dell'avviamento di almeno $250 milioni, che potrebbe aumentare man mano che prosegue la valutazione.

ModivCare Inc. notificó a la SEC que no puede presentar a tiempo su informe trimestral correspondiente al trimestre cerrado el 30 de junio de 2025, porque necesita más tiempo para completar una evaluación por deterioro del goodwill y para finalizar una investigación realizada por asesores externos, ordenada por el Comité de Auditoría, sobre denuncias de la línea de cumplimiento, incluidas cuestiones relacionadas con la cultura de la empresa. La compañía indica que estos asuntos son materiales para sus estados financieros consolidados interinos.

ModivCare también advierte que los ingresos consolidados, el EBITDA y el EBITDA ajustado del trimestre se esperan significativamente inferiores respecto al mismo periodo del año anterior, impulsados en parte por un deterioro del goodwill previsto de no menos de $250 millones, que podría ser mayor a medida que avance la evaluación.

ModivCare Inc.� 분기말이 2025� 6� 30�� 분기� 분기보고서를 기한 � 제출� � 없다� SEC� 통지했습니다. 이는 영업�(굿윌) 손상평가� 완료하고 감사위원회의 지시에 따라 외부 법률자문� 수행� 컴플라이언스 핫라� 관� 제기사항(회사 문화 관� 사안 포함)� 대� 조사� 마무리하� � 시간� � 필요하기 때문입니�. 회사� 이러� 사안들이 연결 중간재무제표� 중요하다� 밝혔습니�.

또한 ModivCare� 해당 분기� 연결 매출, EBITDA � 조정 EBITDA가 전년 동기 대� 상당� 낮을 것으� 예상되며, 이는 부분적으로 최소 $250 million� 영업� 손상� 예상되기 때문이며 평가가 진행됨에 따라 � 커질 � 있다� 경고했습니다.

ModivCare Inc. a informé la SEC qu'elle ne peut pas déposer dans les délais son rapport trimestriel pour le trimestre clos le 30 juin 2025, car elle a besoin de temps supplémentaire pour achever une évaluation de la dépréciation du goodwill et pour finaliser une enquête menée par des conseillers externes, ordonnée par le comité d'audit, portant sur des allégations reçues via la hotline de conformité, y compris des questions liées à la culture d'entreprise. La société indique que ces éléments sont significatifs pour ses états financiers consolidés intermédiaires.

ModivCare avertit également que le chiffre d'affaires consolidé, l'EBITDA et l'EBITDA ajusté du trimestre devraient être sensiblement inférieurs à ceux de la période correspondante de l'année précédente, en partie en raison d'une dépréciation attendue du goodwill d'au moins 250 millions de dollars, qui pourrait augmenter au fur et à mesure de l'avancement de l'évaluation.

ModivCare Inc. teilte der SEC mit, dass es seinen Quartalsbericht für das zum 30. Juni 2025 endende Quartal nicht fristgerecht einreichen kann, da mehr Zeit benötigt wird, um eine Wertminderung des Geschäfts- oder Firmenwerts (Goodwill) abzuschließen und eine vom Prüfungsausschuss veranlasste Untersuchung durch externe Rechtsberater zu Vorwürfen aus der Compliance-Hotline, einschließlich Angelegenheiten zur Unternehmenskultur, zu beenden. Das Unternehmen erklärt, dass diese Angelegenheiten für seine konsolidierten Zwischenabschlüsse wesentlich sind.

ModivCare warnt außerdem, dass der konsolidierte Umsatz, das EBITDA und das bereinigte EBITDA für das Quartal voraussichtlich deutlich unter dem Vorjahreszeitraum liegen werden, teilweise bedingt durch eine erwartete Goodwill-Abschreibung von mindestens $250 Millionen, die im weiteren Verlauf der Bewertung noch größer ausfallen könnte.

Positive
  • Timely disclosure: Company filed a Form 12b-25 to notify the market of the delay rather than withholding information.
  • Audit Committee oversight: The company has engaged outside counsel at the Audit Committee's direction, indicating governance action on compliance allegations.
  • Transparency on expected impact: Management disclosed an anticipated goodwill impairment amount (not less than $250 million) and that results will be significantly lower, providing advance notice to investors.
Negative
  • Significant expected impairment: Anticipated goodwill impairment of not less than $250 million, which could be larger, is a material negative to equity and book value.
  • Operating results set to decline: Company expects consolidated revenue, EBITDA and Adjusted EBITDA for the quarter to be significantly lower than the prior-year period.
  • Investigation into compliance and culture: An Audit Committee–directed outside-counsel probe of hotline allegations raises governance and reputational risk.
  • Delay in filing: Failure to file the quarter on time signals reporting and control challenges that increase investor uncertainty.

Insights

TL;DR: Material earnings hit likely from a sizeable goodwill write-down, reducing near-term operating metrics and complicating quarter reporting.

ModivCare's disclosure that it expects a goodwill impairment of at least $250 million and materially lower revenue and EBITDA is a clear negative for near-term financial performance and may pressure leverage and covenant metrics depending on balance sheet composition and existing debt. The delayed 10-Q increases short-term uncertainty about precise results and any related non-cash charges or tax effects. Investors should expect volatility around the eventual filing as impairment size and any restatements or adjustments are detailed.

TL;DR: Governance response shows oversight but raises concerns about internal controls and culture that prompted an Audit Committee–led probe.

The engagement of outside counsel at the Audit Committee's direction and public disclosure of an investigation into hotline allegations indicate the board is taking the matters seriously, which is positive for oversight. However, the need for an investigation into compliance and culture issues, combined with a material anticipated impairment, suggests potential weaknesses in risk management and internal controls. The delay in filing itself highlights process strain in financial reporting controls.

ModivCare Inc. ha informato la SEC di non poter depositare tempestivamente il proprio rapporto trimestrale relativo al trimestre chiuso il 30 giugno 2025, perché necessita di tempo aggiuntivo per completare una valutazione di svalutazione dell'avviamento (goodwill) e per concludere un'indagine svolta da consulenti esterni, disposta dal Comitato di Revisione, sulle segnalazioni per la compliance hotline, incluse questioni legate alla cultura aziendale. L'azienda dichiara che tali questioni sono rilevanti per i suoi bilanci consolidati interinali.

ModivCare avverte inoltre che i ricavi consolidati, l'EBITDA e l'Adjusted EBITDA del trimestre dovrebbero essere significativamente inferiori rispetto allo stesso periodo dell'anno precedente, in parte per via di una prevista svalutazione dell'avviamento di almeno $250 milioni, che potrebbe aumentare man mano che prosegue la valutazione.

ModivCare Inc. notificó a la SEC que no puede presentar a tiempo su informe trimestral correspondiente al trimestre cerrado el 30 de junio de 2025, porque necesita más tiempo para completar una evaluación por deterioro del goodwill y para finalizar una investigación realizada por asesores externos, ordenada por el Comité de Auditoría, sobre denuncias de la línea de cumplimiento, incluidas cuestiones relacionadas con la cultura de la empresa. La compañía indica que estos asuntos son materiales para sus estados financieros consolidados interinos.

ModivCare también advierte que los ingresos consolidados, el EBITDA y el EBITDA ajustado del trimestre se esperan significativamente inferiores respecto al mismo periodo del año anterior, impulsados en parte por un deterioro del goodwill previsto de no menos de $250 millones, que podría ser mayor a medida que avance la evaluación.

ModivCare Inc.� 분기말이 2025� 6� 30�� 분기� 분기보고서를 기한 � 제출� � 없다� SEC� 통지했습니다. 이는 영업�(굿윌) 손상평가� 완료하고 감사위원회의 지시에 따라 외부 법률자문� 수행� 컴플라이언스 핫라� 관� 제기사항(회사 문화 관� 사안 포함)� 대� 조사� 마무리하� � 시간� � 필요하기 때문입니�. 회사� 이러� 사안들이 연결 중간재무제표� 중요하다� 밝혔습니�.

또한 ModivCare� 해당 분기� 연결 매출, EBITDA � 조정 EBITDA가 전년 동기 대� 상당� 낮을 것으� 예상되며, 이는 부분적으로 최소 $250 million� 영업� 손상� 예상되기 때문이며 평가가 진행됨에 따라 � 커질 � 있다� 경고했습니다.

ModivCare Inc. a informé la SEC qu'elle ne peut pas déposer dans les délais son rapport trimestriel pour le trimestre clos le 30 juin 2025, car elle a besoin de temps supplémentaire pour achever une évaluation de la dépréciation du goodwill et pour finaliser une enquête menée par des conseillers externes, ordonnée par le comité d'audit, portant sur des allégations reçues via la hotline de conformité, y compris des questions liées à la culture d'entreprise. La société indique que ces éléments sont significatifs pour ses états financiers consolidés intermédiaires.

ModivCare avertit également que le chiffre d'affaires consolidé, l'EBITDA et l'EBITDA ajusté du trimestre devraient être sensiblement inférieurs à ceux de la période correspondante de l'année précédente, en partie en raison d'une dépréciation attendue du goodwill d'au moins 250 millions de dollars, qui pourrait augmenter au fur et à mesure de l'avancement de l'évaluation.

ModivCare Inc. teilte der SEC mit, dass es seinen Quartalsbericht für das zum 30. Juni 2025 endende Quartal nicht fristgerecht einreichen kann, da mehr Zeit benötigt wird, um eine Wertminderung des Geschäfts- oder Firmenwerts (Goodwill) abzuschließen und eine vom Prüfungsausschuss veranlasste Untersuchung durch externe Rechtsberater zu Vorwürfen aus der Compliance-Hotline, einschließlich Angelegenheiten zur Unternehmenskultur, zu beenden. Das Unternehmen erklärt, dass diese Angelegenheiten für seine konsolidierten Zwischenabschlüsse wesentlich sind.

ModivCare warnt außerdem, dass der konsolidierte Umsatz, das EBITDA und das bereinigte EBITDA für das Quartal voraussichtlich deutlich unter dem Vorjahreszeitraum liegen werden, teilweise bedingt durch eine erwartete Goodwill-Abschreibung von mindestens $250 Millionen, die im weiteren Verlauf der Bewertung noch größer ausfallen könnte.


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SEC FILE NUMBER
001-34221
CUSIP NUMBER
6078X104
FORM 12b-25
NOTIFICATION OF LATE FILING

(Check one):
Form 10-K
Form 20-F
Form 11-K
Form 10-Q
Form 10-D
Form N-CEN
Form N-CSR
For Period Ended: June 30, 2025

Transition Report on Form 10-K
Transition Report on Form 20-F
Transition Report on Form 11-K
Transition Report on Form 10-Q
For the Transition Period Ended:     


Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this Form shall be construed to imply that the Commission has verified any
information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART I — REGISTRANT INFORMATION
ModivCare Inc.
Full Name of Registrant
Former Name if Applicable
6900 E. Layton Avenue, 12th Floor
Address of Principal Executive Office (Street and Number)
Denver, CO 80237
City, State and Zip Code







PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
(a)
The reason described in reasonable detail in Part III of this Form could not be eliminated without unreasonable effort or expense;
(b)The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
(c)
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
PART III — NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

ModivCare Inc. (the “Company”) is unable file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (the “Form 10-Q”) by the prescribed due date without unreasonable effort or expense because the Company requires additional time to complete its ongoing assessment of goodwill for potential impairment and to report the results of such analysis in its consolidated interim unaudited financial statements. In addition, the Company requires additional time to complete an investigation being conducted by the Company’s outside counsel at the direction of the Audit Committee of the Company’s Board of Directors with respect to compliance hotline allegations, including matters related to the Company's culture.


PART IV — OTHER INFORMATION
(1)Name and telephone number of person to contact in regard to this notification
L. Heath Sampson(303)728-7030
(Name)(Area Code)(Telephone Number)
(2)Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
Yes ☒ No ☐
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
Yes ☒ No ☐
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
The Company anticipates that its consolidated revenue, EBITDA and Adjusted EBITDA that will be included in the Form 10-Q and/or earnings materials will be lower significantly as compared to the amounts included in the Company’s Quarterly Report on Form 10-Q and/or earnings materials for the corresponding periods reported for the last fiscal year due in part to an expected goodwill impairment of not less than $250 million, which amount could be greater due to the on-going goodwill assessment described above.

Cautionary Note Regarding Forward-Looking Statements

This filing contains “forward-looking” statements within the meaning of federal securities laws. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. The Company advises caution in reliance on forward-looking statements. Forward-looking statements include, without limitation, statements related to the expected financial results for the quarter ended June 30, 2025 and the amounts of the expected goodwill impairments. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those implied by the forward-looking statement. The words “estimates,” “expects,” “anticipates,” “believes” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future results. We disclaim and do not undertake any obligation to update or revise any forward-looking statement in this report, except as required by applicable law or regulation. See also other risks that are described in “Risk Factors” in the Company’s filings with the Securities and Exchange Commission (the “SEC”), including its Annual Report on Form 10-K filed with the SEC for the fiscal year ended December 31, 2024, and any subsequent reports filed with the SEC. All forward-looking statements contained herein are based on information available to the Company as of the date of this filing. The Company expressly disclaims any obligation to update or alter its forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.



ModivCare Inc.
(Name of registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date:
August 12, 2025
By: /s/ L. Heath Sampson
L. Heath Sampson
Chief Executive Officer

FAQ

Why did ModivCare (MODV) file a Form 12b-25 notifying a late 10-Q?

The company needs more time to complete a goodwill impairment assessment and to finish an Audit Committee–directed outside-counsel investigation into compliance hotline allegations and culture issues.

Which report is affected by ModivCare's notification?

The company's Quarterly Report for the quarter ended June 30, 2025 (Form 10-Q) is the subject of the late filing notification.

Does ModivCare expect material changes to its quarterly results?

Yes. The company anticipates consolidated revenue, EBITDA and Adjusted EBITDA will be significantly lower than the corresponding prior-year period.

How large is the expected goodwill impairment at ModivCare?

ModivCare disclosed an expected goodwill impairment of not less than $250 million, and said the amount could be greater as the assessment continues.

Have ModivCare's other SEC reports been filed on time?

Yes. The company indicated that all other periodic reports required during the preceding 12 months have been filed.

Who can be contacted about this notification?

Contact listed is L. Heath Sampson, Chief Executive Officer, phone (303) 728-7030.
Modivcare Inc

NASDAQ:MODV

MODV Rankings

MODV Latest News

MODV Latest SEC Filings

MODV Stock Data

34.88M
12.09M
16.38%
68.33%
4.64%
Medical Care Facilities
Transportation Services
United States
DENVER